Eric Hollander, MD
Spectrum Neuroscience and Treatment Institute · Montefiore Medical Center/Albert Einstein College of Medicine · Albert Einstein College of Medicine
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Eric Hollander, MD as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 05:33 UTC. Open this list on ClinicalTrials.gov
- N/ANCT05166707 · An ERP-based Mobile Intervention as an Adjunctive Treatment for OCDBIXINK Therapeutics Co., Ltd. · unknown · Obsessive-compulsive Disorders and Symptoms, Obsessive-Compulsive Disorder · principal investigator
- Ph2NCT03848481 · CBDV vs Placebo in Children and Adults up to Age 30 With Prader-Willi Syndrome (PWS)Eric Hollander · terminated · Prader-Willi Syndrome · principal investigator
- Ph2NCT03202303 · Cannabidivarin (CBDV) vs. Placebo in Children With Autism Spectrum Disorder (ASD)Montefiore Medical Center · completed · Autism Spectrum Disorder · principal investigator
- Ph2NCT03197662 · Intranasal Oxytocin vs. Placebo for the Treatment of Hyperphagia in Prader-Willi SyndromeEric Hollander · completed · Prader-Willi Syndrome, Hyperphagia · principal investigator
- Ph2NCT02629991 · Oxytocin vs. Placebo for the Treatment Hyperphagia in Children and Adolescents With Prader-Willi SyndromeMontefiore Medical Center · completed · Prader-Willi Syndrome, Hyperphagia · principal investigator
- N/ANCT01784744 · Hyperthermia and the Amelioration of Autism SymptomsMontefiore Medical Center · completed · Autism Spectrum Disorder · principal investigator
- Ph4NCT01337700 · Milnacipran in Autism and the Functional Locus Coeruleus and Noradrenergic Model of AutismMontefiore Medical Center · completed · Autism Spectrum Disorder, Asperger Syndrome, Aspergers Syndrome · principal investigator
- N/ANCT01337687 · Intranasal Oxytocin for the Treatment of Autism Spectrum DisordersMontefiore Medical Center · completed · Autism Spectrum Disorders · principal investigator
- Ph2NCT01275248 · Efficacy and Safety Study of Low-Dose Ondansetron For Adjunctive Therapy In Adult Patients With Obsessive-Compulsive DisorderTranscept Pharmaceuticals · terminated · Obsessive-compulsive Disorder · study chair
- Ph1NCT01040221 · Trichuris Suis Ova in Autism Spectrum DisordersMontefiore Medical Center · completed · Autism · principal investigator
- Ph4NCT00565422 · Efficacy of Escitalopram in the Treatment of Internet AddictionIcahn School of Medicine at Mount Sinai · completed · Internet Addiction · principal investigator
- Ph3NCT00245583 · Topiramate in the Treatment of Pathological GamblingIcahn School of Medicine at Mount Sinai · terminated · Pathological Gambling · principal investigator
- Ph4NCT00245635 · Fluoxetine in Pediatric Body Dysmorphic DisorderMontefiore Medical Center · completed · Body Dysmorphic Disorder · principal investigator
- Ph4NCT00211796 · Divalproex Sodium ER in Adult AutismMontefiore Medical Center · completed · Autism · principal investigator
- Ph4NCT00211809 · CBT as an Adjunct to SRIs in the Treatment of BDDIcahn School of Medicine at Mount Sinai · terminated · Body Dysmorphic Disorder · principal investigator
- N/ANCT00211822 · Functional Magnetic Resonance Imaging (fMRI) Studies in Pathological Gambling (PG) and Obsessive-Compulsive Disorder (OCD)Icahn School of Medicine at Mount Sinai · terminated · Pathological Gambling, Obsessive Compulsive Disorder · principal investigator
- N/ANCT00027404 · Study of Fluoxetine in Adults With Autistic DisorderIcahn School of Medicine at Mount Sinai · completed · Autistic Disorder · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 05:33 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. 1 other NIH projects list an investigator with the same name at a different institution and are left out. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
PubMed returned no clinical-trial papers for this author name.